THE SYNDROME OF LEFT VENTRICLE HYPERTROPHY
https://doi.org/10.15829/1560-4071-2014-9-6-10
Abstract
Authors, based on their own experience of the left ventricle hypertrophy treatment, I and by modern literature exploration di analyze three leading diseases, in phenotype of those the left ventricle hypertrophy and its typical central hemodynamic disorders I play crucial role. Arterial hypertension, involutionary calcified aortic stenoses, 1 bicuspid aorto-valvulopathy, hypertrophic cardiomyopathy totally hold leading position in the structure of cardiovascular modbidity. Having the same phenotypical I marks, these diseases absolutely different by their genetic disorders and, I respectively, require completely different treatment strategies. Taking into account the social influence of the left ventricle hypertrophy syndrome due to its prevalence, a serious epidemiological studies on the national level are required.
About the Authors
S. L. Dzemeshkevitch
FSBSU Russian Scientific Centre of Surgery N.A. Academic B. V. Petrovsky, Moscow, Russia.
Russian Federation
Russian Federation
E. V. Zaklyasminskaya
FSBSU Russian Scientific Centre of Surgery N.A. Academic B. V. Petrovsky, Moscow, Russia.
Russian Federation
Russian Federation
Yu. V. Frolova
FSBSU Russian Scientific Centre of Surgery N.A. Academic B. V. Petrovsky, Moscow, Russia.
Russian Federation
Russian Federation
References
1. Puzyrev VP, Karpov RS. Genetics of hypertension. In the book: Guidelines on arterial hypertension (Ed.— EI. Chazov, I. E. Chazova), M: Media-Medica, 2005, pp.61-79. Russian (Пузырев В. П., Карпов Р. С. Генетика артериальной гипертонии. В кн.: Руководство по артериальной гипертонии (Ред.— Е. И. Чазов, И. Е. Чазова), М: Медиа Медика, 2005, с.61-79).
2. Chazov EI, Chazova IE. Ed. Guidelines on arterial hypertension. M: Media-Medica, 2005. Russian (Чазов Е.И., Чазова И. Е. (Ред.) Руководство по артериальной гипертонии. М: Медиа Медика, 2005).
3. Jung B, Gohlke-Barwolf C, Tornos P, et al. Recomendations of the management of the asymptomatic patient with valvular heart disease. Eur. Heart J., 2002; 23, 16:1253.
4. Stewart BF, Siscovick D, Lind BK. Clinical factors associated with calcific aortic valve disease. A Coll Cardiol., 1997; 29:630.
5. Wierzbicki A, Shetty Ch. Aortic stenosis: an atherosclerotic disease? J. Heart Valve Dis., 1999; 8, 4:416.
6. Kim KM, Valigorsky JM, Mergner WJ, et al. Aging changes in the human aortic valve in relation to dystrophic calcification. Hum. Pathol., 1976; 7:47.
7. Mohler ERIII, Chawla MK, Chang AW, et al. Identification of calcifying valve cells from human and canine aortic valves. J. Heart Valve Dis., 1999; 8, 3: 254.
8. Dzemeshkevich SL, Stevenson LU, Alexi-Meskhishvili VV. Diseases of aortic valve function, diagnosis treatment. M: GEOTAR-MED, 2004. Russian (Дземешкевич С. Л., Стивенсон Л. У., Алекси-Месхишвили В.В. Болезни аортального клапана: функция, диагностика лечение. М.: ГЭОТАР-МЕД, 2004).
9. Grande KJ, Cochran RP, Reinhall PG, et al. Mechanismus of aortic valve incompetence in aging: a finite element model. J. Heart Valve Dis., 1999; 8, 2: 147.
10. Dobsin PB. Pathophysiology and pathogenesisof aortic aneurysms. Current concepts. Surg. Clin. North Am., 1989; 69: 687.
11. Maron BJ, Ferrance VJ, Roberts WC. Myocardial ultrastructure in patients with chronic aortic valve disease. Am. J. Cardiol., 1975; 35: 725.
12. Areskog NH. Exercise testing in the evaluation of patints with valvular aortic stenosis. Clin. Physiol., 1984; 4: 201.
13. Corte A, Body SC, Booher AM, et al. Surgical treatment of bicuspid aortic valve disease: knowledge gaps and research perspectives. Thorac Cardiovasc Surg, 2014; 147,6:1749.
14. Dzemeshkevich SL, Ivanov VA, Charchyan ER, et al. Bileaflet aortic valve (the evolution of views on a particular type of valvulopathy). Russ J Cardiol, 2014, 5 (109): 49-54. Russian (Дземешкевич С. Л., Иванов В. А., Чарчян Э.Р и др. Двухстворчатый аортальный клапан (эволюция взглядов на особый тип вальвулопатии). Российский кардиологи¬ческий журнал, 2014, 5 (109): 49-54).
15. Garg V, Muth AN, Ransom JF, et al. Mutations in NOTCH 1 cause aortic valve disease. Nature, 2005, 437: 270-4.
16. Padang R, Bagnall R, Semsarian Ch, et al. The genetic basis of familial valvular heart disease. Circ. Cardiovasc. Genet., 2012, 55: 569-80.
17. an HL, Glen E, Topf A, et al. Nonsynonymous variants in the SMAD 6 gene predispose to congenital cardiovascular malformation/ Hum. Mutat. 2012, 33:720-7.
18. Maron BJ, Gradin JM, Flack JM, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Circulation, 1995; 92, 4: 785-9.
19. Hagege A. Modern treatment of hyperthrophic cardiomyopathy. Clin. Experiment. Surg. Petrovsky J., 2014; 1: 90-5.
20. Zaklyazminskaya EV. Genetic diversity causes hypertrophy of the myocardium. Clin and experiment. hir. The magazine is named after academician I. P Petrovsky, 2014; 1: 23-8. Russian (Заклязьминская Е. В. Генетическое разнообразие причин гипертрофии миокарда. Ж.клин. и эксперимент. хир. им.акад. Б. В. Петровского, 2014; 1: 23-8).
21. Raskin VV, Frolova YV, Malikova MS, et al. Tactics of surgical treatment of patients with generalized form of hypertrophic obstructive cardiomyopathy. Clin and experiment. hir The magazine is named after academician I. P. Petrovsky, 2014; 1: 100-3. Russian (Раскин В. В., Фролова Ю. В., Маликова М. С. и др. Тактика хирургического лечения пациентов с генерализованной формой обструктивной гипертрофической кардиомиопатии. Ж.клин. и эксперимент. хир. им.акад. Б. В. Петровского, 2014; 1; 100-3.
22. Gutermann H, Pettikari M, van Kerrebroeck Ch, et al. Myectomy and mitral repair through the left atrium in hypertrophic obstructive cardiomyopathy: contemporary surgical candidates? J Thorac Cardiovasc Surg, 2014; 147: 1833-6.
23. Krylov NS, Krylova AA, Poteshkina IG. Differential diagnosis of hypertrophic cardiomyopathy and hypertrophic heart with exercise tests. Russ J Cardiol, 2014, 5 (109), 29-34. Russian (Крылова Н. С., Крылов А. А., Потешкина И. Г. Дифференциаль ная диагностика гипертрофической кардиомиопатии и гипертрофического сердца с помощью тестов с физической нагрузкой. Российский кардиологический журнал, 2014, 5 (109), 29-34).
24. Poljakov RS, Sahakian YM, Puretzky MV, et al. Interventional techniques for the treatment of hypertrophic cardiomyopathy. Clin and experiment. hir The magazine is named after academician I. P Petrovsky, 2014; 1: 96-9. Russian (Поляков Р. С., Саакян Ю.М., Пурецкий М. В. и др. Интервенционные методы лечения гипертрофической кардио- миопатии. Ж. клин. и эксперимент. хир. им. акад. Б. В. Петровского, 2014; 1, 96-9).
25. Schaff NV, Dearani JA, Ommen SR, et al. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operations in patients with latent obstruction. J Thorac Cardiovasc Surg, 2012;143, 2: 303-9.
Review
For citations:
Dzemeshkevitch S.L., Zaklyasminskaya E.V., Frolova Yu.V. THE SYNDROME OF LEFT VENTRICLE HYPERTROPHY. Russian Journal of Cardiology. 2014;(9):6-10. (In Russ.) https://doi.org/10.15829/1560-4071-2014-9-6-10
Views:
1864
Email this article 